A detailed history of Sachetta, LLC transactions in Novartis Ag stock. As of the latest transaction made, Sachetta, LLC holds 3,503 shares of NVS stock, worth $340,071. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,503
Previous 3,503 -0.0%
Holding current value
$340,071
Previous $392 Million 2.76%
% of portfolio
0.16%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$92.57 - $107.37 $1,943 - $2,254
-21 Reduced 0.6%
3,503 $392 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $325,159 - $357,826
3,524 New
3,524 $356 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.